Savara Pharmaceuticals
SVRA
#6301
Rank
A$0.91 B
Marketcap
$5.58
Share price
4.72%
Change (1 day)
3.86%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -A$0.12 B

According to Savara Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$0.12 B. In 2023 the company made an earning of -A$81.01 M a decrease over its 2022 earnings that were of -A$56.5 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.12 B40.63%
2023 -A$81.01 M43.38%
2022 -A$56.5 M-11.31%
2021 -A$63.7 M-13.3%
2020 -A$73.48 M-36.53%
2019 -A$0.12 B13.76%
2018 -A$0.11 B105.54%
2017 -A$49.52 M34.11%
2016 -A$36.92 M-37.43%
2015 -A$59.01 M38.81%
2014 -A$42.51 M33.62%
2013 -A$31.82 M38.49%
2012 -A$22.97 M24.59%
2011 -A$18.44 M-36.5%
2010 -A$29.04 M-3.14%
2009 -A$29.98 M-23.28%
2008 -A$39.07 M8.52%
2007 -A$36.01 M-34.14%
2006 -A$54.67 M184.43%
2005 -A$19.23 M90.75%
2004 -A$10.08 M190.35%
2003 -A$3.48 M11.64%
2002 -A$3.11 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$26.89 M-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.37 B 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA